Rosenfeldt et al., 2004 - Google Patents
Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitisRosenfeldt et al., 2004
- Document ID
- 8571988473900885902
- Author
- Rosenfeldt V
- Benfeldt E
- Valerius N
- Pærregaard A
- Michaelsen K
- Publication year
- Publication venue
- The Journal of pediatrics
External Links
Snippet
OBJECTIVE: To determine whether probiotic lactobacilli may alleviate small intestinal inflammation and strengthen the intestinal barrier function in children with atopic dermatitis. STUDY DESIGN: In a double-blinded, placebo-controlled, cross-over study, probiotic …
- 201000008937 atopic dermatitis 0 title abstract description 41
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23Y—INDEXING SCHEME RELATING TO LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23Y2220/00—Lactobacillus
- A23Y2220/73—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0291—Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/96—Cosmetic or similar toilet preparations characterised by the composition containing material, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetic or similar toilet preparations characterised by the composition containing material, or derivatives thereof of undetermined constitution from micro-organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rosenfeldt et al. | Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis | |
| Nocerino et al. | Cow's milk and rice fermented with Lactobacillus paracasei CBA L74 prevent infectious diseases in children: a randomized controlled trial | |
| Myllyluoma et al. | Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy–a placebo‐controlled, double‐blind randomized pilot study | |
| Ezendam et al. | Probiotics: immunomodulation and evaluation of safety and efficacy | |
| DE60028003T2 (en) | BIFIDOBACTERIUM FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| Bausserman et al. | The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial | |
| Cruchet et al. | Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children | |
| Niv et al. | The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome—a double blind, placebo-controlled, randomized study | |
| Abrahamsson et al. | Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial | |
| Pacifico et al. | Probiotics for the treatment of Helicobacter pylori infection in children | |
| Savino et al. | Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial | |
| Pantoflickova et al. | Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis | |
| RU2560440C2 (en) | Lactobacillus plantarum strain as hypocholesterolemic agents (versions) and application thereof | |
| JP4455333B2 (en) | Probiotic bacteria: Lactobacillus fermentum | |
| Gaon et al. | Effect of lactobacillus strains (L. casei, L. acidophillus strains CERELA) on bacterial overgrowth-related chronic diarrhea | |
| Zaharoni et al. | Probiotics improve bowel movements in hospitalized elderly patients—The proage study | |
| US20090169531A1 (en) | Use of symbiotic for the treatment of atopic dermatitis | |
| NZ732197A (en) | Gold kiwifruit compositions and methods of preparation and use therefor | |
| KR102475432B1 (en) | Novel probiotic formulation for modulating intestinal immunity | |
| KR102390806B1 (en) | Use of probiotics in the treatment and/or prevention of atopic dermatitis | |
| WO1997046104A1 (en) | Treatment of diarrhea | |
| Ouwehand et al. | Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection | |
| JP7220677B2 (en) | Lipid lowering effect of Bacillus coagulans | |
| KR20210005717A (en) | Probiotic Bifidobacterium Brevet Strains and Compositions Containing the Strains | |
| Ten Bruggencate et al. | The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study |